ABVC BIOPHARMA, INC. ABVC
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2004-11-09
ABVC BIOPHARMA, INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | 99.9% | -98.1% | 70.5% | 98.6% | 96.1% | 97.1% | -2563.6% | — | — |
| Operating margin | -2416.0% | -923.3% | -4439.2% | -1558.5% | -3290.1% | -1760.9% | -492.9% | -40031.1% | — | — |
| Net margin | -2671.8% | -962.1% | -5109.3% | -1693.5% | -3608.5% | -2193.1% | -560.5% | -87184.2% | — | — |
| FCF margin | — | — | -2760.6% | -775.2% | -2140.3% | — | — | — | — | — |
| Return on assets | -37.5% | -65.0% | -100.0% | -171.4% | -93.7% | -91.3% | -56.8% | -102.1% | -160.5% | -147.8% |
| Return on equity | -59.5% | -399.9% | -501.1% | -507.5% | -144.7% | -308.1% | 2605.4% | 107.2% | 241.5% | 292.3% |
| Current ratio | 0.41 | 0.33 | 0.27 | 0.54 | 2.07 | 1.27 | 0.13 | 0.05 | 0.60 | — |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.